Month: March 2009
-
FDA Panel Rejects Stryker’s OP-1 Bone Product
A Food and Drug Administration panel of medical experts said a Stryker Corp. (SYK) spinal “putty” should not be approved…
Read More » -
Another Independent Proxy Advisor Recommends Against All 4 Ramius Nominees for Orthofix Board
BOSTON–(BUSINESS WIRE)–Orthofix International N.V. (NASDAQ: OFIX) (the Company) announced today that independent proxy advisor Egan-Jones Proxy Services has recommended against…
Read More » -
Vertos Readies for Commercialization with New Headquarters, Training Center and Strategic Hires
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Vertos Medical, Inc., a privately held medical device manufacturer that developed the proprietary mild® (Minimally Invasive Lumbar…
Read More » -
Dr. Robert D’agostini Offers a New Solution for Knee Pain
BEDMINSTER, N.J.–(BUSINESS WIRE)–New Jersey residents suffering from knee pain can finally take a sigh of relief thanks to the availability…
Read More » -
Ramius Forced to Retract False Statement about Orthofix Chairman
BOSTON–(BUSINESS WIRE)–Orthofix International N.V. (NASDAQ: OFIX) (the Company) announced today that the activist hedge fund, Ramius, has been forced to…
Read More » -
Biomet Announces Expiration of Deferred Prosecution Agreement
WARSAW, Ind.–(BUSINESS WIRE)–Biomet, Inc. announced today that the Deferred Prosecution Agreement (DPA) entered into effective September 27, 2007 with the…
Read More » -
VG Innovations pursues patent for back device
VG Innovations Inc. isn’t bashful about its prospects. The medical-devices startup company, based in Winston-Salem, said it is offering a…
Read More » -
BioMedical Enterprises, Inc. (BME) Announces the Appointment of Keith M. Peeples as Vice President, Sales and Marketing
SAN ANTONIO, March 30 /PRNewswire/ — BioMedical Enterprises, Inc.(BME), a rapidly growing medical device company focused on the clinicaldevelopment of…
Read More » -
Mesoblast Limited (ASX:MSB) Raises Capital Of A$10.81 Million For New Clinical Programs
Melbourne, Mar 30, 2009 (ABN Newswire) – Mesoblast Limited (ASX:MSB)(PINK:MBLTY) Australia’s regenerative medicine company, today announced that it has successfully…
Read More » -
Zimmer Announces Expiration of Deferred Prosecution Agreement
WARSAW, Ind., March 30 /PRNewswire-FirstCall/ — Zimmer Holdings, Inc. (NYSE: ZMH – News; SWX: ZMH – News), a leader in…
Read More » -
United States Patent & Trademark Office (USPTO) Rules in Smith & Nephew’s Favor and Confirms Patent Claims Infringed by Arthrex Inc.
ANDOVER, Mass., March 30 /PRNewswire-FirstCall/ — The United States Patent & Trademark Office (USPTO) overruled Arthrex’s validity challenges to the…
Read More » -
Corin Swings To Fiscal Year Loss On Weak Cormet Sales
LONDON -(Dow Jones)- Orthopedic device company Corin Group PLC (CRG.LN) Monday said it swung to a full-year loss following inventory…
Read More » -
Glass Lewis Calls for Change on the Orthofix Board
NEW YORK–(BUSINESS WIRE)–RCG Starboard Advisors, LLC, an affiliate of Ramius LLC (collectively, “Ramius”), today announced that Glass Lewis & Co,…
Read More » -
NIH Awards $1.66 Million Grant to Evaluate Cerashield™ Coating to Reduce Orthopedic Implant Infections
DENVER–(BUSINESS WIRE)–Ceragenix Pharmaceuticals, Inc.(“Ceragenix”) (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology today announced that the National…
Read More » -
ConforMIS Expands Executive Team with Addition of Medical Device Industry Veterans
BURLINGTON, Mass.–(BUSINESS WIRE)–ConforMIS, Inc., a medical device company that develops and commercializes patient-specific solutions for the treatment of osteoarthritis and…
Read More »